Publication Type : Journal Article
Publisher : Walter de Gruyter GmbH
Source : Drug Metabolism and Personalized Therapy
Url : https://doi.org/10.1515/dmpt-2024-0033
Keywords : microsatellite instability; DNA mismatch repair; colon adenocarcinoma; colorectal cancer; Wnt; AXIN2; RNF43; ETV4
Campus : Kochi
School : School of Medicine
Department : Medical Oncology
Year : 2024
Abstract :
Objectives : The prevalence of microsatellite instability (MSI) subtype among all colon cancers in India is about 30 %, approximately two times more than that of western population suggesting different molecular pathogeneses.
Methods : A NanoString analysis-based Pan cancer differential expression (DE) profile was determined in a primary cohort of early-stage CRC (tumor=10, normal=7), and correlated against MSI status. Using RT-PCR, tumor-specific DE genes were validated in another cohort of MSI-high CRC (n=15).
Results : Among the most differentially expressed genes, AXIN2, ETV4, and RNF43 were tumor cell-specific signals, while a set of genes including COL11A1, COMP, INHBA, SPP1, MMP3, TLR2, and others were immune cell-specific signals, that had a differential expression between MSI and MSS groups. When overlapped with The Cancer Genome Atlas (TCGA) studies using the Tumor immune estimation resource tool (TIMER), and protein-protein interaction analysis by STRING.db, these genes were segregated to representative tumor cells and immune cells. On validation, the tumor-specific gene signals were inversely associated with TLR4 expression.
Conclusions : The differential expression distribution of AXIN2, ETV4, and RNF43 among tumor and immune cells, suggests more than one pathological subset in the MSI-H subgroup of early-stage CRC in the Indian population.
Cite this Research Publication : Prasanth Ariyannur, Veena P. Menon, Keechilat Pavithran, Roopa R. Paulose, Reenu A. Joy, Damodaran M. Vasudevan, Molecular pathogenesis of microsatellite instability-high early-stage colorectal adenocarcinoma in India, Drug Metabolism and Personalized Therapy, Walter de Gruyter GmbH, 2024, https://doi.org/10.1515/dmpt-2024-0033